MedTrace Logo

Primary Aldosteronism In Hypertensive Patients in China

NCT03155139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2020-10-23

No results posted yet for this study

Summary

To investigate the prevalence of primary aldosteronism (PA) in Chinese patients with newly diagnosed hypertension.

Conditions

  • Hyperaldosteronism; Primary
  • Hypertension Secondary

Interventions

DIAGNOSTIC_TEST

Aldosterone/renin ratio (ARR) testing

Plasma aldosterone concentration tests, Direct renin concentration tests

DIAGNOSTIC_TEST

Confirmatory tests

Captopril challenge test, Saline infusion test

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    collaborator OTHER

  • Qifu Li

    lead OTHER

Principal Investigators

  • Jun Cai, phD · Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-03
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155139 on ClinicalTrials.gov